Canopy Growth Corporation Common Shares CGC

Zacks Investment Research 12 nov

Canopy Growth Corporation (CGC) is receiving heavy investor attention, but the stock has underperformed significantly, declining 15.4% over the past month compared to the S&P 500's 2.4% decline. The company faces challenges with negative earnings estimates, a Zacks Rank #4 (Sell) rating, and premium valuation metrics relative to peers. While revenue is expected to grow modestly, earnings estimate revisions have been negative, suggesting the stock may underperform the broader market in the near term.

The Motley Fool 8 nov

An analysis of five major cannabis stocks reveals significant differences in financial health. Cronos Group leads with approximately $841 million in cash and no significant debt, followed closely by SNDL, which is debt-free with positive free cash flow. Tilray and Canopy Growth continue to struggle with debt and negative cash flow despite some revenue growth, while Aurora Cannabis has a smaller liquidity cushion. A strong balance sheet provides financial flexibility but doesn't guarantee profitability or shareholder returns.

Zacks Investment Research 6 nov

Canopy Growth reported a Q2 loss of $0.07 per share, significantly worse than the consensus estimate of $0.02 loss, representing a -250% earnings surprise. Revenue of $58.15 million missed estimates by 1.63%, though it improved from $48.42 million year-ago. The stock has declined 40.7% year-to-date and carries a Zacks Rank #3 (Hold) rating with mixed estimate revisions.

Zacks Investment Research 5 nov

Concentra Group (CON) reported quarterly earnings of $0.52 per share, beating consensus estimates of $0.45 and surpassing revenue expectations with $622.12 million. The company has outperformed the market by 121.3% year-to-date and received a Zacks Rank #2 (Buy) rating. Canopy Growth Corporation (CGC) is expected to report a quarterly loss of $0.02 per share with revenues projected at $59.12 million.

The Motley Fool 30 oct

Tilray Brands maintains a 4x revenue advantage over Canopy Growth, consistently generating $200+ million quarterly revenue compared to Canopy's $45-73 million. While both companies show year-over-year growth when comparing comparable quarters, Tilray demonstrates more stable and higher revenue levels. Canopy's latest Q4 2025 quarter ($73.3M) suggests potential momentum, but the revenue gap remains substantial.